Últimas noticias sobre Westlake (NYSE:WLK) Bolsa

Westlake

Westlake Corp is a manufacturer and supplier of chemicals, polymers and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

Las acciones más sobrevendidas de materiales según su RSI: MP Materials, AptarGroup y Westlake ofrecen oportunidades para inversores atentos.

Acciones más sobrevendidas en materiales: MP Materials, AptarGroup y Westlake

Westlake Corp

WALKABOUT RES LTD by Walkabout Resource Limited

Westlake Chemical Partners LP Common Units representing limited partner interests

Westlake Chemical Partners LP

WILK TECHNOLOGIES LTD by WILK TECHNOLOGIES LTD.

Wilk Technologies Ltd

Westlake Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) will release its fourth-quarter financial results, before the opening <a href="https://www.benzinga.com/quote/WLK/earnings">bell, on Monday, Feb. 24, 2025.</a>
Analysts expect the Houston, Texas-based company to report quarterly earnings at $1.17 per share, up from 53 cents per share in the year-ago period. Westlake projects quarterly revenue of $2.97 billion, compared to $2.83 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Nov. 5, the company posted weaker-than-expected third-quarter earnings.
Westlake shares fell 1.9% to close at $111.40 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/WLK/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Citigroup analyst Patrick Cunningham upgraded the stock from Neutral to Buy and cut the price target from $152 to $140 on Dec. 18, 2024. This analyst has an accuracy rate of 63%.</li>
<li>BMO Capital analyst John McNulty maintained a Market Perform rating and lowered the price target from $171 to $165 on Nov. 13, 2024. This analyst has an accuracy rate of 63%.</li>
<li>UBS analyst Joshua Raskin maintained a Neutral rating and cut the price target from $160 to $144 on Nov. 6, 2024. This analyst has an accuracy rate of 80%.</li>
<li>Wells Fargo analyst Michael Sison maintained an Overweight rating and cut the price target from $180 to $160 on Nov. 6, 2024. This analyst has an accuracy rate of 67%.</li>
<li>JP Morgan analyst Jeffrey Zekauskas maintained an Underweight rating and raised the price target from $123 to $135 on Aug. 15, 2024. This analyst has an accuracy rate of 67%.</li>
</ul>
Considering buying WLK stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="597" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21040916/image-177-1024x597.png" alt="" class="wp-image-792653" style="width:640px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21040916/image-177-1024x597.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21040916/image-177-300x175.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21040916/image-177-768x448.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21040916/image-177.png 1093w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43864993/top-3-health-care-stocks-you-may-want-to-dump-in-february">Top 3 Health Care Stocks You May Want To Dump In February</a></li>
</ul>

Earnings

Price Target

Analyst Ratings

Top Wall Street Forecasters Revamp Westlake Price Expectations Ahead Of Q4 Earnings

Truist Securities analyst Peter Osterland initiated coverage on several chemicals stocks <a href="https://www.benzinga.com/analyst-stock-ratings">ahead of earnings release</a>.
Chemours Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CC#NYSE">CC</a>): The analyst initiated coverage with a Buy rating and <a href="https://www.benzinga.com/quote/CC/analyst-ratings">a price forecast of $27</a>. The analyst writes that the company is positioned to achieve strong earnings growth in 2025-2026.
Osterland sees margin expansion in its Opteon refrigerant franchise and a potential rebound in the underperforming TiO2 segment, where consensus estimates appear overly conservative.
Valuation upside exists as the new management team executes cost optimization strategies and focuses on higher-value product applications, adds the analyst.
Osterland estimates EBITDA of $775 million (in line), $1.004 billion (+8% vs. Street), and $1.188 billion (+11% vs. Street) for 2024, 2025, and 2026, respectively.
The analyst assumes ~6% average revenue growth in 2025-2026 (above the company's &gt;5% target) and consolidated EBITDA margins reaching 18.3% by 2026 (vs. Street's 17.1%).
Tronox Holdings plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TROX#NYSE">TROX</a>): Osterland initiated coverage with a Buy rating <a href="https://www.benzinga.com/quote/trox/analyst-ratings">and price forecast of $17.</a> The analyst sees the company as one of the strongest players in the TiO2 industry, benefiting from its scale and strong vertical integration, which have helped sustain margins better than peers during the downturn.
With improving TiO2 market fundamentals and potential support from anti-dumping duties on Chinese exports, the analyst expects above-market volume growth and significant earnings upside as operating rates recover.
The analyst estimates EBITDA of $563 million (in line with Street), $694 million (+6% vs Street), and $802 million (+6% vs Street) in 2024, 2025, and 2026, respectively.
Minerals Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTX#NYSE">MTX</a>): The analyst initiated coverage with a Buy rating and <a href="https://www.benzinga.com/quote/mtx/analyst-ratings">a price forecast of $103</a>. Osterland writes that the company's unique mineral reserves, engineering expertise, and strong market positions create a competitive edge which is undervalued relative to peers.
The analyst expects sustainable mid-single-digit revenue growth driven by diverse opportunities, modest upside to consensus estimates for 2025-2026, and potential upward revision to the company&#8217;s medium-term operating margin target.
The analyst estimates EBITDA of $404 million (in line with Street), $440 million (+3% vs Street), and $471 million (+4% vs Street) for 2024, 2025, and 2026 respectively.
Westlake Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>): Osterland initiated coverage with a Buy rating and <a href="https://www.benzinga.com/quote/wlk/analyst-ratings">price forecast of&nbsp;$168</a>. The analyst says that the company has built a vertically integrated market leader through its synergistic chemicals and building products strategy.
With a strong ~$3 billion cash balance, the company has flexibility for further HIP expansion via M&amp;A or increased shareholder returns, adds the analyst.
Osterland estimates EBITDA of $2.377 billion (in line with Street), $2.677 billion (+5% vs Street), and $2.996 billion (+5% vs Street) in 2024, 2025, and 2026, respectively.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/node/43269986">Taiwan Semiconductor Stock Rebounds After Selloff, US-Taiwan Chip Partnership Still Faces Tariff Threats</a></li>
</ul>
Photo via Shutterstock.

Analyst Color

Equities

Large Cap

Mid Cap

Initiation

TROX

Chemours, Tronox And Westlake Will See Earnings Rebound In Chemical Sector Amid TiO2 Recovery And Margin Expansion: Analyst

BofA Securities analyst Dimple Gosai revised the rating or price forecast on several <a href="https://www.benzinga.com/topic/clean-energy">clean energy stocks </a>ahead of the earnings results.
First Solar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>): The analyst cut the price forecast from $246 to $236, <a href="https://www.benzinga.com/quote/FSLR/analyst-ratings">while maintaining a Buy rating.</a>
The analyst writes that updates on the A/D ruling will be pivotal for pricing power, though near-term customer commitments may stay limited.
The analyst says that monitoring warranty remediation costs and the shift of India-manufactured supply to the U.S. will be crucial for evaluating capacity utilization and gross margin gains.
For FY24/FY25, Gosai estimates revenue of $1.502 billion with an adj. EBITDA margin of 44.6% and $5.516 billion with a 55% margin (slightly above consensus).
Fluence Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>): The analyst cut the price forecast from $25 to $20, <a href="https://www.benzinga.com/quote/flnc/analyst-ratings">while reiterating a Buy rating.</a>
Taking about the key focus areas, the analyst expects FY25 revenue cover to rise to the mid-80% range, 25% of U.S. projects to use domestic cells in FY25 and maintain stability in market share.
Gosai estimates revenue of $361 million and gross margin of 12.7% ahead of consensus at $257 million and 11.1% for first quarter 2025.
For FY25, the analyst sees revenue of $3.84 billion near the middle of the guidance range ($3.6 billion-$4.4 billion).
HA Sustainable Infrastructure Capital, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HASI#NYSE">HASI</a>): Gosai retained the price forecast of &nbsp;$37 and <a href="https://www.benzinga.com/quote/hasi/analyst-ratings">a Buy rating on the stock</a>.
The analyst writes that the company&#8217;s key factors to watch include progress on the >$5.5 billion pipeline, developments in the KKR partnership, and the stability of asset yields.
The analyst expects to closely monitor guidance updates, particularly regarding the projected 8%-10% annual adjusted EPS growth through 2026 and the outlook for 2027 amidst policy uncertainties.
The analyst's adjusted EPS estimate for fourth-quarter is 61 cents (slightly higher than the consensus of 59 cents) and for 2024 stands at $2.43 (vs. $2.41 consensus).
Clearway Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWEN#NYSE">CWEN</a>): The analyst maintained the price forecast of $32 and a <a href="https://www.benzinga.com/quote/cwen/analyst-ratings">Buy rating on the stock</a>.
Gosai anticipates that wind production data from key western states could provide upside during the seasonally weaker fourth-quarter.
The analyst highlights updates on the path to achieving the 2027 CAFD guidance as a key factor, noting recent M&amp;A activity, including Tuolumne Wind, and the offer of Honeycomb, which add visibility toward reaching the $2.50 midpoint.
The analyst estimates 2024 EBITDA/CAFD of $1.17 billion/$406 million (roughly in-line) and 2025 EBITA/CAFD of 1.24 billion/$432 million (above consensus).
Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>): The analyst cut the price forecast from $20 to $18, while <a href="https://www.benzinga.com/quote/be/analyst-ratings">reiterating an Underperform rating</a>.
Gosai says that key focus areas for the company include ensuring stability in order flow, securing greenfield projects, and tracking developments related to ITC impacts, which are pivotal for project economics.
While utility partnerships are expected to increase, maintaining cost competitiveness and improving margins will be critical for achieving the company&#8217;s goals, adds the analyst.
The analyst's 2024 revenue estimate falls at the lower end of the guidance range of $1.4 billion-$1.6 billion, and expects gross margins to be below consensus at 24.3%, vs. the 26.6% consensus and 28% guidance.
Also, the analyst sees 2025 revenue and EBITDA below consensus.
The AES Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AES#NYSE">AES</a>): The analyst maintained the price forecast of $11 and an <a href="https://www.benzinga.com/quote/aes/analyst-ratings">Underperform rating on the stock</a>.
The analyst expects the outlook for the near term to be impacted by one-off headwinds, including the expiration of the Warrior Run PPA, divestitures in Brazil and Ohio, and droughts in Columbia. FLNC monetization is not expected in the near term.
The analyst says they are looking for updates on the $3.5 billion asset sale program while anticipating near-term EPS dilution and execution risks in the renewables segment.
Gosai estimates 2024 EBITDA of $2.65 billion, at the lower end of the $2.6 billion-$2.9 billion guidance and in line with consensus at $2.66 billion.
Read Next:<a href="https://www.benzinga.com/25/01/43109461/gold-miners-defense-stocks-shine-while-solar-tanks-following-trumps-day-1-actions"></a>
<ul>
<li><a href="https://www.benzinga.com/25/01/43109461/gold-miners-defense-stocks-shine-while-solar-tanks-following-trumps-day-1-actions">Trump&#8217;s First Day Sends Gold Miners, Defense Stocks Soaring, Solar Sliding</a></li>
</ul>
Photo: Shutterstock

Tech

CWEN

FLNC

FSLR

Hannon Armstrong Sustainable Infrastructure Capital

HASI

6 Clean Energy Stocks Face Challenges, Opportunities Ahead Of Earnings

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Truist Securities analyst Peter Osterland initiated coverage on Albemarle Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) with a Hold rating and announced a price target of $96. Albemarle shares closed at $88.78 on Monday. <a href="https://www.benzinga.com/quote/ALB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>BMO Capital analyst Juan Sanabria initiated coverage on Tanger Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKT#NYSE">SKT</a>) with a Market Perform rating and announced a price target of $36. Tanger shares closed at $32.68 on Monday. <a href="https://www.benzinga.com/quote/SKT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Truist Securities analyst Peter Osterland initiated coverage on Westlake Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Buy rating and announced a price target of $168. Westlake shares closed at $117.57 on Monday. <a href="https://www.benzinga.com/quote/WLK/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler analyst Mark Lear initiated coverage on Expand Energy Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXE#NASDAQ">EXE</a>) with a Neutral rating and announced a price target of $96. Expand Energy shares closed at $101.42 on Monday. <a href="https://www.benzinga.com/quote/EXE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Evercore ISI Group analyst Gavin Clark-Gartner initiated coverage on Mind Medicine (MindMed) Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNMD#NASDAQ">MNMD</a>) with an Outperform rating and announced a price target of $23. Mind Medicine shares closed at $6.90 on Monday. <a href="https://www.benzinga.com/quote/MNMD/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying WLK stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="608" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/28071609/image-220-1024x608.png" alt="" class="wp-image-753404" style="width:484px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/28071609/image-220-1024x608.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/28071609/image-220-300x178.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/28071609/image-220-768x456.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/28071609/image-220.png 1107w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/01/43230206/jim-cramer-is-worried-about-this-consumer-cyclical-stock-7-yield-something-may-be-wrong-here">Jim Cramer Is Worried About This Consumer Cyclical Stock: 7% Yield? &#8216;Something May Be Wrong Here&#8217;</a></li>
</ul>

MNMD

This Westlake Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Truist Securities analyst Peter Osterland initiates coverage on Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Buy rating and announces Price Target of $168.

Truist Securities Initiates Coverage On Westlake with Buy Rating, Announces Price Target of $168

Morgan Stanley analyst Neel Kumar maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Equal-Weight and lowers the price target from $155 to $130.

Morgan Stanley Maintains Equal-Weight on Westlake, Lowers Price Target to $130

Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) in the last three months.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Westlake, presenting an average target of $151.75, a high estimate of $167.00, and a low estimate of $135.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 5.38%. 
<img src="https://www.benzinga.com/files/images/story/2025/1736546455_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Westlake. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Maintains</td>
<td>Buy</td>
<td>$144.00</td>
<td>$144.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$135.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$140.00</td>
<td>$152.00</td>
</tr>
<tr>
<td>John McNulty</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$165.00</td>
<td>$171.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$167.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Joshua Raskin</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$144.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$160.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Steve Byrne</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$159.00</td>
<td>$151.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Westlake. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Westlake compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Westlake's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Westlake's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/WLK/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Westlake analyst ratings.</a>
<h2>Delving into Westlake's Background</h2>
Westlake Corp is a manufacturer and supplier of chemicals, polymers and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.
<h3>Key Indicators: Westlake's Financial Health</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Growth: Westlake's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 0.06%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Westlake's net margin is impressive, surpassing industry averages. With a net margin of 3.43%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Westlake's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.01% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.51%, the company showcases effective utilization of assets.
Debt Management: With a below-average debt-to-equity ratio of 0.5, Westlake adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>What Are Analyst Ratings?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: Westlake In The Eyes Of 8 Experts

UBS analyst Joshua Spector upgrades Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) from Neutral to Buy and maintains the price target from $144 to $144.

Upgrades

UBS Upgrades Westlake to Buy, Maintains Price Target to $144

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Mp Materials Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>)</h3>
<ul>
<li>On Dec. 9, MP Materials announced exchanges of a portion of its 0.25% green convertible senior notes due 2026, representing a net reduction of $25 million of outstanding indebtedness. The company' stock fell around 1% over the past month and has a<a href="https://www.benzinga.com/quote/MP"> 52-week low of $10.02</a>.</li>
<li>RSI Value: 29.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>MP Price Action: Shares of MP closed at $19.38 on Wednesday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1">latest MP news</a>. </li>
</ul>
<figure class="wp-block-image is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1"><img decoding="async" src="blob:https://editorial.benzinga.com/33b2eabd-d190-4861-894a-21adfadc832c" alt="" style="width:677px;height:auto" /></a></figure>
<h3 class="wp-block-heading">Aptargroup Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On Jan. 7, Raymond James analyst Matt Roberts initiated coverage on AptarGroup with an Outperform rating and announced a price target of $200. The company's stock fell around 10% over the past month and <a href="https://www.benzinga.com/quote/ATR">has a 52-week low</a> of $124.94.</li>
<li>RSI Value: 28.6</li>
<li>ATR Price Action: Shares of Aptargroup closed at $154.15 on Wednesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1">ATR stock</a>. </li>
</ul>
<figure class="wp-block-image is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1"><img decoding="async" src="blob:https://editorial.benzinga.com/5e2009b7-bacf-4c30-8efa-8883d6f10ec9" alt="" style="width:640px;height:auto" /></a></figure>
<h3 class="wp-block-heading">Westlake Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>)</h3>
<ul>
<li>On Jan. 7, Piper Sandler analyst Charles Neivert maintained Westlake with an Overweight and lowered the price target from $155 to $135.. The company's stock fell around 10% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/wlk">low of $108.95.</a></li>
<li>RSI Value: 19.8</li>
<li>WLK Price Action: Shares of Westlake fell 0.1% to close at $110.54 on Wednesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1"> WLK shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="902" height="852" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10085621/image-58.png" alt="" class="wp-image-728154" style="width:645px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10085621/image-58.png 902w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10085621/image-58-300x283.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10085621/image-58-768x725.png 768w" sizes="(max-width: 902px) 100vw, 902px" /></a></figure>
Read This Next:<a href="https://www.benzinga.com/25/01/42900074/how-to-earn-500-a-month-from-synovus-financial-stock-ahead-of-q4-earnings"> </a>
<ul>
<li><a href="https://www.benzinga.com/25/01/42900074/how-to-earn-500-a-month-from-synovus-financial-stock-ahead-of-q4-earnings">How To Earn $500 A Month From Synovus Financial Stock Ahead Of Q4 Earnings</a></li>
</ul>

Top 3 Materials Stocks That Are Set To Fly This Month

Piper Sandler analyst Charles Neivert maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Overweight and lowers the price target from $155 to $135.

Piper Sandler Maintains Overweight on Westlake, Lowers Price Target to $135

Citigroup analyst Patrick Cunningham upgrades Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) from Neutral to Buy and lowers the price target from $152 to $140.

Citigroup Upgrades Westlake to Buy, Lowers Price Target to $140

BMO Capital analyst John McNulty maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Market Perform and lowers the price target from $171 to $165.

BMO Capital Maintains Market Perform on Westlake, Lowers Price Target to $165

RBC Capital analyst Arun Viswanathan maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Outperform and lowers the price target from $170 to $167.

RBC Capital Maintains Outperform on Westlake, Lowers Price Target to $167

<a href="https://www.ft.com/content/de2ac6e1-c5ef-4b0a-aa70-c936c46fe9f3" title="https://www.ft.com/content/de2ac6e1-c5ef-4b0a-aa70-c936c46fe9f3">https://www.ft.com/content/de2ac6e1-c5ef-4b0a-aa70-c936c46fe9f3</a>

Legal

ATKR

OTTR

'DoJ Investigates Potential Price-Fixing In PVC Pipe Market' - Financial Times

WIIM

Westlake shares are trading lower after Wells Fargo and UBS lowered their respective price targets on the stock.

In the last three months, 9 analysts have published ratings on Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>), offering a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $162.56, a high estimate of $180.00, and a low estimate of $135.00. Observing a 0.62% increase, the current average has risen from the previous average price target of $161.56. 
<img src="https://www.benzinga.com/files/images/story/2024/1730926823_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Westlake among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joshua Raskin</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$144.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$160.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Steve Byrne</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$159.00</td>
<td>$151.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$170.00</td>
<td>$174.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$180.00</td>
<td>$162.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$170.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$174.00</td>
<td>$157.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$135.00</td>
<td>$123.00</td>
</tr>
<tr>
<td>John McNulty</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$171.00</td>
<td>$167.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Westlake. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Westlake compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Westlake's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into Westlake's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/WLK/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Westlake analyst ratings.</a>
<h2>Discovering Westlake: A Closer Look</h2>
Westlake Corp is a manufacturer and supplier of chemicals, polymers and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.
<h3>Breaking Down Westlake's Financial Performance</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Negative Revenue Trend: Examining Westlake's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -1.35% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Westlake's net margin is impressive, surpassing industry averages. With a net margin of 9.7%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Westlake's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.98% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Westlake's ROA excels beyond industry benchmarks, reaching 1.48%. This signifies efficient management of assets and strong financial health.
Debt Management: Westlake's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.55.
<h2>The Significance of Analyst Ratings Explained</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Navigating 9 Analyst Ratings For Westlake

UBS analyst Joshua Raskin maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Neutral and lowers the price target from $160 to $144.

UBS Maintains Neutral on Westlake, Lowers Price Target to $144

Wells Fargo analyst Michael Sison maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Overweight and lowers the price target from $180 to $160.

Wells Fargo Maintains Overweight on Westlake, Lowers Price Target to $160

Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) reported quarterly earnings of $1.41 per share which missed the analyst consensus estimate of $2.21 by 36.2 percent. The company reported quarterly sales of $3.117 billion which missed the analyst consensus estimate of $3.305 billion by 5.69 percent. This is a 0.06 percent increase over sales of $3.115 billion the same period last year.

Earnings Misses

Westlake Q3 2024 Adj. EPS $1.41 Misses $2.21 Estimate, Sales $3.117B Miss $3.305B Estimate

Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) is set to give its latest quarterly earnings report on Tuesday, 2024-11-05. Here's what investors need to know before the announcement.
Analysts estimate that Westlake will report an earnings per share (EPS) of $2.33. 
Anticipation surrounds Westlake's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Performance in Previous Earnings</h3>
During the last quarter, the company reported an EPS beat by $0.41, leading to a 0.37% drop in the share price on the subsequent day.
Here's a look at Westlake's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.99</td>
<td>1.02</td>
<td>0.90</td>
<td>1.97</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.40</td>
<td>1.34</td>
<td>0.72</td>
<td>2.20</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-0.0%</td>
<td>0.0%</td>
<td>2.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1730739657_0.png" alt="eps graph" />
<h3>Tracking Westlake's Stock Performance</h3>
Shares of Westlake were trading at $132.14 as of November 01. Over the last 52-week period, shares are up 9.9%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Views on Westlake</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Westlake.
Analysts have provided Westlake with 8 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $166.12, suggesting a potential 25.72% upside.
<h3>Comparing Ratings with Competitors</h3>
In this analysis, we delve into the analyst ratings and average 1-year price targets of Cabot, Olin and PureCycle Technologies, three key industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>The consensus among analysts is an Neutral trajectory for Cabot, with an average 1-year price target of $101.5, indicating a potential 23.19% downside.</li>
<li>As per analysts' assessments, Olin is favoring an Neutral trajectory, with an average 1-year price target of $49.22, suggesting a potential 62.75% downside.</li>
<li>PureCycle Technologies received a Buy consensus from analysts, with an average 1-year price target of $9.33, implying a potential 92.94% downside.</li>
</ul>
<h3>Insights: Peer Analysis</h3>
The peer analysis summary offers a detailed examination of key metrics for Cabot, Olin and PureCycle Technologies, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Westlake</td>
<td>Outperform</td>
<td>-1.35%</td>
<td>$664M</td>
<td>2.98%</td>
</tr>
<tr>
<td>Cabot</td>
<td>Neutral</td>
<td>4.96%</td>
<td>$256M</td>
<td>7.96%</td>
</tr>
<tr>
<td>Olin</td>
<td>Neutral</td>
<td>-4.90%</td>
<td>$134.50M</td>
<td>-1.19%</td>
</tr>
<tr>
<td>PureCycle Technologies</td>
<td>Buy</td>
<td>0.00%</td>
<td>$-22.22M</td>
<td>-15.34%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Westlake ranks at the top for Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.
<h3>About Westlake</h3>
Westlake Corp is a manufacturer and supplier of chemicals, polymers and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.
<h3>A Deep Dive into Westlake's Financials</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Negative Revenue Trend: Examining Westlake's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -1.35% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Westlake's net margin excels beyond industry benchmarks, reaching 9.7%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Westlake's ROE stands out, surpassing industry averages. With an impressive ROE of 2.98%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Westlake's ROA stands out, surpassing industry averages. With an impressive ROA of 1.48%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Westlake's debt-to-equity ratio is below the industry average at 0.55, reflecting a lower dependency on debt financing and a more conservative financial approach.
<a href="https://www.benzinga.com/quote/WLK/earnings">To track all earnings releases for Westlake visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Westlake

Noticias

Últimas noticias sobre Westlake (NYSE:WLK) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL